IR 05000037/2019002: Difference between revisions

From kanterella
Jump to navigation Jump to search
(Created page by program invented by StriderTol)
(Created page by program invented by StriderTol)
 
Line 1: Line 1:
{{Adams
#REDIRECT [[IR 015000037/2019002]]
| number = ML19091A109
| issue date = 04/25/2019
| title = One Source Inspection, LLC - NRC Inspection 15000037/2019002
| author name = Burritt A
| author affiliation = NRC/RGN-I/DNMS/CRDB
| addressee name = Mesa M
| addressee affiliation = One Source Inspection LLC
| docket = 15000037
| license number = PA-1545
| contact person =
| case reference number = EA-19-004
| document report number = IR 2019002
| document type = Letter
| page count = 3
}}
 
{{IR-Nav| site = 05000037 | year = 2019 | report number = 002 }}
 
=Text=
{{#Wiki_filter:UNITED STATES rch 25, 2019
 
==SUBJECT:==
ONE SOURCE INSPECTION, LLC - NRC INSPECTION NO. 15000037/2019002
 
==Dear Mr. Mesa,==
This letter refers to the inspection conducted on March 12, 2019, at the temporary jobsite location at 200 New Tank Hill Road, Worthington, WV 26591 (39.4719951; -80.3014903). This inspection examined activities conducted under your license as they relate to public health and safety, and to confirm compliance with the Commission's rules and regulations and with the conditions of your license. Within these areas, the inspection consisted of selected examination of procedures and representative records, observations of activities, and interviews with personnel.
 
The inspector reviewed your compliance with personnel dosimetry requirements under 10 CFR 34.47 and determined that One Source Inspection, LLC, is using direct ion storage (DIS) dosimetry designed for remote data evaluation to meet these requirements. The inspector reviewed the conditions described in NRC Enforcement Guidance Memorandum-18-001 (EGM-18-001) and found that: (1) the DIS dosimeters are being provided and dose data evaluated and reported for the dose of record by an NVLAP-accredited processor, (2) the licensee and the NVLAP-accredited processor have implemented specified quality controls to ensure that the dosimeter is calibrated and/or replaced appropriately, and (3) the licensee has maintained the necessary documentation and records to demonstrate that the criteria of EGM-18-001 are being implemented. The NRC has determined that the implementation of your InstadoseTM dosimetry system meets the criteria of EGM-18-001, dated May 11, 2018.
 
Within the scope of this inspection, no violations were identified.
 
In accordance with 10 CFR 2.390 of the NRCs "Rules of Practice," a copy of this letter will be made available electronically for public inspection in the NRC Public Document Room or from the NRC document system (ADAMS), accessible from the NRC Web site at http://www.nrc.gov/reading-rm/adams.html. You are not required to respond to this letter.
 
However, if you choose to provide additional information, to the extent possible, your response should not include any personal privacy, proprietary, or safeguards information so that it can be made available to the Public without redaction.
 
If you have any questions regarding this matter, please contact James Cassata of my staff at 610-337-5303 or via electronic mail at james.cassata@nrc.gov. Thank you for your cooperation.
 
Sincerely,
/RA/
Arthur Burritt, Chief Commercial, Industrial, R&D and Academic Branch Division of Nuclear Materials Safety Region I Docket No. 15000037 License No. PA-1545 cc:
Commonwealth of Pennsylvania ONE SOURCE INSPECTION, LLC - NRC INSPECTION NO. 15000037/2019002 DATED March 25, 2019.
 
DOCUMENT NAME: G:\WBL Documents\WBL Inspection Reports\RPA-1545.2019002.docx ML19091A109 X Non-Sensitive  X Publicly Available X SUNSI Review Sensitive  Non-Publicly Available OFFICE R1:DNMS RI/ORA  R1/DNMS NAME JCassata/jc MMcLaughlin/mm ABurritt/ab DATE 03/15/2019 3/21/19  3/25/19 OFFICIAL RECORD COPY
}}

Latest revision as of 11:22, 2 February 2020